Most specimens represented chemotherapy-naive tumour and results might have been confounded by other mechanisms that control TUBB3 expression, such as hypoxia via transcription factors HIF-1α/HIF-2α [72, 73] epigenetic modifications [74] or differences in warm ischaemia time and treatments rendered. This evidence concerns the gene TUBB3 and neoplasm.